Roche: signs cloud, software deal with Veeva
(CercleFinance.com) - Roche and Veeva on Monday signed a deal under which the Swiss drugmaker will use the cloud-based software maker's services to streamline its clinical, regulatory, and quality processes.
Veeva said the Basel-based company will switch to unified applications to increase efficiency and enhance data quality, while standardising its clinical applications.
Speeding drug development is a strategic priority for drugmakers like Roche, Veeva said.
San Francisco-based Veeva offers cloud solutions for research, regulatory and commercial applications for the life sciences industry. The company's software is used by companies such as Alcon, GSK, Gilead, and Illumina.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
Veeva said the Basel-based company will switch to unified applications to increase efficiency and enhance data quality, while standardising its clinical applications.
Speeding drug development is a strategic priority for drugmakers like Roche, Veeva said.
San Francisco-based Veeva offers cloud solutions for research, regulatory and commercial applications for the life sciences industry. The company's software is used by companies such as Alcon, GSK, Gilead, and Illumina.
Copyright (c) 2020 CercleFinance.com. All rights reserved.